Novonco Therapeutics is a pharmaceutical company based in Los Angeles, California, specializing in the development of innovative cancer treatments. Situated in the 90025 postal code area, this organization focuses on advancing therapeutic options to address unmet medical needs in oncology. Their work encompasses a range of pharmaceutical research and development activities aimed at creating novel drug candidates for patients affected by various forms of cancer.
Operating from a strategic location in Los Angeles, Novonco Therapeutics engages in both preclinical and clinical phases of drug development. The company’s efforts include the design, synthesis, and testing of new compounds intended to improve the efficacy and safety profiles of cancer therapies. By collaborating with medical experts and research institutions, the organization seeks to contribute meaningful advancements to the pharmaceutical industry, particularly in the realm of targeted cancer treatments.
Novonco Therapeutics maintains a commitment to scientific rigor and innovation, utilizing contemporary methodologies and technologies to facilitate drug discovery and development. The company’s work is supported by a team of experienced professionals dedicated to exploring molecular mechanisms and therapeutic pathways that may lead to improved patient outcomes. Through its focused approach, Novonco Therapeutics plays a role in the evolving landscape of pharmaceutical solutions for oncology.
Located at 12100 Wilshire Boulevard, Novonco Therapeutics serves as a hub for pharmaceutical research in the Los Angeles area. Contact can be made via telephone at 310-806-9202 for inquiries related to their pharmaceutical projects and collaborations. The company’s presence in this major metropolitan area positions it within a vibrant network of scientific and medical resources that support ongoing innovation in cancer treatment development.


































